title: Mycobacterium abscessus and M. avium trigger Toll-like receptor 2 and distinct cytokine response in human cells.
abstract: Mycobacterium avium (MAV) and M. abscessus (MAB) are ubiquitous environmental organisms increasingly recognized to cause chronic lung disease in patients with apparently normal immune function. Little is yet known about their human pathophysiology. Our objective was to examine cytokine and chemokine responses (protein and gene expression) and signaling pathways triggered by reference and clinical isolates of MAB and MAV in human peripheral blood mononuclear cells, monocytes, and murine bone marrow-derived macrophages in vitro. MAB-induced TNF-alpha production was higher than that induced by MAV. IFN-gamma, IL-1beta, and the chemokines macrophage inflammatory protein-1alpha and regulated on activation, normal T cell expressed and secreted were equally up-regulated. Differences between MAB and MAV do not require replication and are heat stable. We found no differential effect due to rough or smooth colonies within the same species. Similar to MAV, MAB triggered mitogen-activated protein kinase (MAPK) signaling and nuclear factor-kappaB translocation. Induction of TNF-alpha was dependent on MAPK pathways, since pre-incubation of cells with signaling inhibitors led to more than 85% reduction in cytokine secretion. MAB also triggered a Toll-like receptor 2 (TLR2)-mediated response that led to TNF-alpha production by human monocytes. Accordingly, stimulation of murine TLR2- or myeloid differentiation factor 88-deficient bone marrow-derived macrophages did not elicit TNF-alpha, reinforcing a critical role for TLR2 in MAB-induced cell activation. We concluded that MAB signals human cells through MAPK and TLR2 pathways and triggers more pronounced pro-inflammatory cytokines and chemokines than MAV.
authors.affiliation: Laboratory of Clinical Infectious Diseases, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892-1684, USA. sampaioe@niaid.nih.gov
authors.forename: Elizabeth P
authors.initials: EP
authors.lastname: Sampaio
authors.forename: Houda Z
authors.initials: HZ
authors.lastname: Elloumi
authors.forename: Adrian
authors.initials: A
authors.lastname: Zelazny
authors.forename: Li
authors.initials: L
authors.lastname: Ding
authors.forename: Michelle L
authors.initials: ML
authors.lastname: Paulson
authors.forename: Alan
authors.initials: A
authors.lastname: Sher
authors.forename: Andre L
authors.initials: AL
authors.lastname: Bafica
authors.forename: Yvonne R
authors.initials: YR
authors.lastname: Shea
authors.forename: Steven M
authors.initials: SM
authors.lastname: Holland
mesh_terms: D000818:Animals; D018925:Chemokines / Q000096:biosynthesis; D016207:Cytokines / Q000096:biosynthesis*; D006801:Humans; D008264:Macrophages / Q000378:metabolism; D051379:Mice; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D009161:Mycobacterium / Q000502:physiology*; D009162:Mycobacterium avium / Q000502:physiology; D016328:NF-kappa B / Q000378:metabolism; D051195:Toll-Like Receptor 2 / Q000378:metabolism*
chemical_list: D018925:Chemokines; D016207:Cytokines; D016328:NF-kappa B; C495342:TLR2 protein, human; C493486:Tlr2 protein, mouse; D051195:Toll-Like Receptor 2; D020928:Mitogen-Activated Protein Kinases